Por favor, use este identificador para citar o enlazar este ítem:
https://hdl.handle.net/11000/35471
Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | RODRIGUEZ DIAZ, JUAN CARLOS | - |
dc.contributor.author | Ruiz García, María Montserrat | - |
dc.contributor.author | López, M. | - |
dc.contributor.author | Royo, Gloria | - |
dc.contributor.other | Departamentos de la UMH::Producción Vegetal y Microbiología | es_ES |
dc.date.accessioned | 2025-01-29T12:31:15Z | - |
dc.date.available | 2025-01-29T12:31:15Z | - |
dc.date.created | 2002-05 | - |
dc.identifier.citation | International Journal of Antimicrobial Agents Volume 20, Issue 6, December 2002, Pages 464-467 | es_ES |
dc.identifier.issn | 1872-7913 | - |
dc.identifier.issn | 0924-8579 | - |
dc.identifier.uri | https://hdl.handle.net/11000/35471 | - |
dc.description.abstract | The in vitro activity of moxifloxacin, gatifloxacin, levofloxacin and linezolid was evaluated against 234 strains of Mycobacterium tuberculosis isolated in the Southeast of Spain. All drugs tested showed good activity, with an MIC90 of less than 1 mg/l, and were active against isociacide and rifampicin resistant strains. Three strains were resistant to isoniazid and to the fluoroquinolones, which suggested the existence of mechanisms of resistance not yet described. These new compounds may prove to be therapeutic alternatives for treatment of multi-resistant tuberculosis and further studies should be done to demonstrate their true usefulness | es_ES |
dc.format | application/pdf | es_ES |
dc.format.extent | 4 | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Elsevier | es_ES |
dc.rights | info:eu-repo/semantics/closedAccess | es_ES |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Mycobacterium tuberculosis | es_ES |
dc.subject | Fluorquinolones | es_ES |
dc.subject | Linezolid | es_ES |
dc.title | In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.relation.publisherversion | https://doi.org/10.1016/S0924-8579(02)00239-X | es_ES |
Ver/Abrir:
1-s2.0-S092485790200239X-main.pdf
91,5 kB
Adobe PDF
Compartir:
La licencia se describe como: Atribución-NonComercial-NoDerivada 4.0 Internacional.